Huang Wenpeng, Zhou Jingwei, Liang Yutong, Saladin Rachel J, Li Liming, Kang Lei, Hua Chen, Cai Weibo
Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Departments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.
Coord Chem Rev. 2025 Jul 15;535. doi: 10.1016/j.ccr.2025.216641. Epub 2025 Mar 29.
Gastrointestinal (GI) malignancies remain to be one of the most prevalent malignancies that are often characterized by a dismal prognosis. Nanoplatforms present a groundbreaking avenue for enhancing targeting strategies and multifunctionality in cancer treatment. The emergence of nanotechnology, particularly the innovation of smart responsive nanomaterials, has revolutionized cancer diagnosis and therapy. This review begins by exploring the design principles of smart responsive nanomaterials, focusing on the various exogenous and endogenous stimuli that drive their functionality. Furthermore, we provide a comprehensive summary of the applications of smart responsive nanomaterials in the treatment of GI malignancies over the past five years. Our aim is to contribute to the growing body of knowledge on smart responsive nanomaterials in GI malignancies, spark innovative ideas, and encourage further advancements in this field. Finally, we discuss the prospects and challenges associated with the use of smart responsive nanomaterials in GI malignancies.
胃肠道(GI)恶性肿瘤仍然是最常见的恶性肿瘤之一,其预后往往很差。纳米平台为增强癌症治疗中的靶向策略和多功能性提供了一条开创性的途径。纳米技术的出现,尤其是智能响应纳米材料的创新,彻底改变了癌症的诊断和治疗。本综述首先探讨智能响应纳米材料的设计原则,重点关注驱动其功能的各种外源性和内源性刺激。此外,我们全面总结了智能响应纳米材料在过去五年中在胃肠道恶性肿瘤治疗中的应用。我们的目标是为胃肠道恶性肿瘤中智能响应纳米材料的知识增长做出贡献,激发创新想法,并鼓励该领域的进一步发展。最后,我们讨论了在胃肠道恶性肿瘤中使用智能响应纳米材料的前景和挑战。
Cochrane Database Syst Rev. 2025-6-20
Cochrane Database Syst Rev. 2017-5-23
Arch Ital Urol Androl. 2025-6-30
Autism Adulthood. 2024-12-2
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2022-9-20
J Psychiatr Ment Health Nurs. 2024-8
Signal Transduct Target Ther. 2024-10-18
Signal Transduct Target Ther. 2024-10-7
Eur J Pharm Biopharm. 2024-11